What happens to my Canadian Aphria stock after merger?
The company will continue to trade on the Nasdaq Global Select Exchange under the symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the symbol "TLRY" on May 5. Under the terms, Aphria shareholders receive 0.8381 of a Tilray share for each common share of Aphria.
Is Aphria buying Tilray?
Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue.
Should I keep Aphria stock?
Aphria Inc(APHA-T) Rating A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Is Aphria a buy or sell?
Currently, Aphria is a Zacks Rank #5 (Strong Sell) in the Medical - Products industry that ranks in the Bottom 41% of our Zacks Industry Rank.
Who merged with Aphria?
TilrayThe mega-merger deal between Canadian cannabis companies Aphria and Tilray (TLRY -4.34%) was the highlight of the marijuana industry this year. The deal closed on May 3 and the "new" Tilray was formed, and in the process, became the world's largest cannabis company by revenue.
Who owns Aphria?
TilrayAphria / Parent organizationTilray Brands, Inc. is a global pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City, New York. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal. Wikipedia
Is Tilray a good buy now?
Shares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now. IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.
Will Aphria go up?
Aphria Inc quote is equal to 4.850 USD at 2022-05-26. Based on our forecasts, a long-term increase is expected, the "APHQF" stock price prognosis for 2023-12-19 is 33.761 USD. With a 5-year investment, the revenue is expected to be around +596.11%. Your current $100 investment may be up to $696.11 in 2027.
Is Tilray a buy sell or hold?
Tilray has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.
Has Tilray and Aphria merged yet?
Tilray-Aphria merger closes, expanded company to control biggest share of Canadian pot market. Canadian cannabis companies Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.
Is Aphria stock delisted?
Aphria Shares will be delisted from the TSX and NASDAQ.
Is Aphria overvalued?
Because Aphria is relatively undervalued, the long-term return of its stock is likely to be higher than its business growth, which averaged 125.7% over the past three years and is estimated to grow 26.56% annually over the next three to five years.